Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population (Q40682677)

22 September 2017

title

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population (English)

1 reference

22 September 2017

main subject

coronary artery disease

1 reference

Wang TD

1

1 reference

22 September 2017

Chen WJ

2

1 reference

22 September 2017

Chien KL

3

1 reference

22 September 2017

Seh-Yi Su SS

4

1 reference

22 September 2017

Hsu HC

5

1 reference

22 September 2017

Chen MF

6

1 reference

22 September 2017

Liau CS

7

1 reference

22 September 2017

Lee YT

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Cardiology

22 September 2017

published in

1 reference

22 September 2017

volume

88

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

737-743

1 reference

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Cholesterol and coronary heart disease: predicting risks by levels and ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan--a unique experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Primary prevention of coronary heart disease: integrating risk assessment with intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

Familial hyper-alpha-lipoproteinemia: Studies in eighteen kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901843-4

10.1016/S0002-9149(01)01843-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference